17.73
0.62%
-0.11
前日終値:
$17.84
開ける:
$17.85
24時間の取引高:
14.91M
Relative Volume:
1.52
時価総額:
$20.09B
収益:
$16.77B
当期純損益:
$-959.00M
株価収益率:
-20.86
EPS:
-0.85
ネットキャッシュフロー:
$1.37B
1週間 パフォーマンス:
-18.22%
1か月 パフォーマンス:
-19.56%
6か月 パフォーマンス:
+1.72%
1年 パフォーマンス:
+46.53%
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile
名前
Teva Pharmaceutical Industries Ltd Adr
セクター
電話
972 (3) 914-8213
住所
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
TEVA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.73 | 20.09B | 16.77B | -959.00M | 1.37B | -0.85 |
ZTS
Zoetis Inc
|
170.90 | 77.10B | 9.15B | 2.43B | 2.31B | 5.32 |
HLN
Haleon Plc Adr
|
9.47 | 42.82B | 14.26B | 1.55B | 0 | 0.3383 |
TAK
Takeda Pharmaceutical Co Adr
|
13.39 | 42.45B | 30.27B | 1.93B | 3.45B | 0.6044 |
NBIX
Neurocrine Biosciences Inc
|
151.82 | 15.37B | 2.24B | 385.90M | 440.10M | 3.73 |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-07-10 | アップグレード | Argus | Hold → Buy |
2024-03-08 | アップグレード | JP Morgan | Underweight → Neutral |
2024-02-12 | アップグレード | Piper Sandler | Neutral → Overweight |
2024-01-23 | アップグレード | Jefferies | Hold → Buy |
2024-01-03 | アップグレード | Piper Sandler | Underweight → Neutral |
2023-12-18 | 開始されました | HSBC Securities | Buy |
2023-11-27 | アップグレード | UBS | Neutral → Buy |
2023-07-06 | アップグレード | UBS | Sell → Neutral |
2023-05-25 | 開始されました | Morgan Stanley | Equal-Weight |
2023-05-18 | アップグレード | Evercore ISI | In-line → Outperform |
2023-01-19 | ダウングレード | Jefferies | Buy → Hold |
2022-11-14 | ダウングレード | JP Morgan | Neutral → Underweight |
2022-11-04 | ダウングレード | UBS | Neutral → Sell |
2022-10-21 | 再開されました | Jefferies | Buy |
2022-08-05 | アップグレード | BofA Securities | Neutral → Buy |
2022-06-14 | 再開されました | UBS | Neutral |
2022-05-17 | アップグレード | BofA Securities | Underperform → Neutral |
2022-05-04 | ダウングレード | Piper Sandler | Neutral → Underweight |
2022-04-05 | アップグレード | Barclays | Equal Weight → Overweight |
2022-03-25 | アップグレード | Bernstein | Mkt Perform → Outperform |
2022-01-27 | ダウングレード | Argus | Buy → Hold |
2021-10-28 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2021-05-04 | ダウングレード | UBS | Buy → Neutral |
2021-04-07 | 再開されました | RBC Capital Mkts | Sector Perform |
2020-11-25 | 開始されました | Oppenheimer | Perform |
2020-08-06 | アップグレード | Barclays | Underweight → Equal Weight |
2020-07-27 | 再開されました | Goldman | Neutral |
2020-06-01 | アップグレード | SunTrust | Hold → Buy |
2020-04-24 | 再開されました | Citigroup | Neutral |
2020-04-06 | アップグレード | UBS | Neutral → Buy |
2020-02-24 | ダウングレード | Edward Jones | Hold → Sell |
2019-11-12 | アップグレード | JP Morgan | Underweight → Neutral |
2019-10-17 | アップグレード | Gabelli & Co | Hold → Buy |
2019-08-07 | ダウングレード | Evercore ISI | Outperform → In-line |
2019-07-19 | 開始されました | Wolfe Research | Peer Perform |
2019-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2019-07-10 | 再開されました | Credit Suisse | Neutral |
2019-07-05 | アップグレード | Argus | Hold → Buy |
2019-06-11 | 開始されました | Barclays | Underweight |
2019-06-03 | アップグレード | Oppenheimer | Perform → Outperform |
2019-05-30 | ダウングレード | BofA/Merrill | Buy → Underperform |
2019-05-28 | ダウングレード | UBS | Buy → Neutral |
2019-03-20 | 開始されました | SunTrust | Hold |
2019-03-07 | 再開されました | UBS | Buy |
すべてを表示
Teva Pharmaceutical Industries Ltd Adr (TEVA) 最新ニュース
TEVA Stock Quote Price and Forecast - CNN
Why Teva Pharmaceutical Stock Is Sinking Today - The Motley Fool
Teva Stock Dives 14%. 'We're Victims Of Our Own Success,' Says CEO. - Investor's Business Daily
Are You Looking for a Top Momentum Pick? Why Sea Limited Sponsored ADR (SE) is a Great Choice - Yahoo Finance
Does Starbucks Corp (NASDAQ: SBUX) Still Need To Convince Analysts? - Stocks Register
Wells Fargo & Co (NYSE: WFC) Jumps 0.80%, Turning Investors Away - Stocks Register
Does Petroleo Brasileiro S.A. Petrobras ADR (NYSE: PBR) Still Look Hot This Week? - Stocks Register
MINISO Group Holding Limited Unsponsored ADR (MNSO) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Exicure Inc (XCUR) requires closer examination - US Post News
Citizens Financial Group Inc (NYSE: CFG) Stock Forecast: Bearish Sentiment Points To -1.52% Downside In 2025 - Stocks Register
Is It Worth Investing in PDD Holdings Inc. Sponsored ADR (PDD) Based on Wall Street's Bullish Views? - Yahoo Finance
Brainsway Ltd. Sponsored ADR (BWAY) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
Hewlett Packard Enterprise Co (NYSE: HPE) Stock Forecast: Could Pass $29 In A Year - Stocks Register
Citigroup Inc (NYSE: C) Up 37.25% This Year: What Is Going To Happen Next - Stocks Register
Where Do Analysts Think The Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Is Going - Stocks Register
Is Capricorn Energy PLC Unsponsored ADR (CRNCY) Stock Outpacing Its Oils-Energy Peers This Year? - Yahoo Finance
New Strong Buy Stocks for January 2nd - Yahoo Finance
Are Medical Stocks Lagging Brainsway (BWAY) This Year? - Yahoo Finance
Fortuna Mining Corp Still Hasn’t Convinced Analysts? - Stocks Register
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) 0.56% Incline Turns Investors Away - Stocks Register
Is Now The Time To Buy Abbvie Inc (NYSE: ABBV) Stock? - Stocks Register
PayPal Holdings Inc (NASDAQ: PYPL) Could Pass $95 In One Year Stock Forecast - Stocks Register
How Do Things Look For Boeing Co (NYSE: BA) In The Short-Term? - Stocks Register
What Did We Note About Insider Trading At Energy Transfer LP (NYSE: ET)? - Stocks Register
SelectQuote Inc Still Hasn’t Convinced Analysts? - Stocks Register
Barclays plc ADR (NYSE: BCS) Stock Sentiment: What’s Wall Street Saying? - Stocks Register
What Did We Note About Insider Trading At Altice USA Inc (NYSE: ATUS)? - Stocks Register
Walmart Inc (NYSE: WMT) -2.05% Decline Turns Investors Away - Stocks Register
What Did We Note About Insider Trading At Microsoft Corporation (NASDAQ: MSFT)? - Stocks Register
Where Do Analysts Think The Itau Unibanco Holding S.A. ADR (NYSE: ITUB) Is Going - Stocks Register
Hewlett Packard Enterprise Co (NYSE: HPE) Up 28.35% This Year: What Is Going To Happen Next - Stocks Register
Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $28.00 at Barclays - MarketBeat
Teva Catapults 26%, Hitting A Six-Year High, After Scoring A Win With Sanofi-Tied Drug - Investor's Business Daily
Sandoz Group AG Sponsored ADR (SDZNY) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet - Yahoo Finance
Is Kingsoft Cloud (KC) Outperforming Other Computer and Technology Stocks This Year? - Yahoo Finance
Opera Gains 27% in 3 Months: Should You Buy, Sell or Hold the Stock? - Yahoo Finance
Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - Yahoo Finance
Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Hello Group Inc. Sponsored ADR (MOMO) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
Are Medical Stocks Lagging Adagene (ADAG) This Year? - Yahoo Finance
Teva Pharmaceutical ADR Gets Relative Strength Rating Upgrade - Investor's Business Daily
Saudi Arabia Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research
Why Novo Nordisk A/S (NVO) Is the Best ADR Stock to Invest in? - Yahoo Finance
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
Best Momentum Stocks to Buy for November 26th - Yahoo Finance
Why MINISO Group Holding Limited Unsponsored ADR (MNSO) Outpaced the Stock Market Today - Yahoo Finance
Petrobras to Distribute R$ 20 Billion in Dividends - Yahoo Finance
10 Stocks With the Largest Fair Value Estimate Increases After Q3 Earnings - Morningstar
Is Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Outperforming Other Consumer Discretionary Stocks This Year? - Yahoo Finance
Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
Teva Pharmaceutical Industries Ltd Adr (TEVA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):